Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | PTPRC | P08575 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27923357 | 0.98 | ALDH1A1 (0.55) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| Acetic Acid SCHEMBL27401419 | 0.94 | ALDH1A1 (0.61) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| Dimethylamine SCHEMBL27585618 | 0.93 | KMT2A (0.55) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| Trimethylammonium SCHEMBL27550267 | 0.93 | ALDH1A1 (0.55) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL9258815 | 0.90 | CA1 (0.47) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| Methyl Carbamate SCHEMBL28506255 | 0.88 | KMT2A (0.55) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL7420439 | 0.88 | MAOB (0.58) | ALDH1A1L3MBTL1SLC6A2SLC6A3PTPN1 | |
| SCHEMBL29079466 | 0.87 | ALDH1A1 (0.60) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL543540 | 0.86 | ALDH1A1 (0.55) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL27694802 | 0.85 | ALDH1A1 (0.50) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534620-A | Preparation method of palladium-catalyzed hydrocarbon bond functionalized 2-trifluoromethyl benzimidazole compound | 六盘水师范学院 | 2024-02-09 | — | — | CN | claimed |
| CN-108883080-A | Novel muramyl peptide derivative compounds, their synthesis and use thereof | 巴拉特生物技术国际有限公司 | 2018-11-23 | — | — | CN | claimed |
| CN-108884132-A | Novel muramyl peptide derivative compound, its synthesis and application thereof | 巴拉特生物技术国际有限公司 | 2018-11-23 | — | — | CN | claimed |
| EP-3389643-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | Bharat Biotech International Limited (IN) | 2018-10-24 | — | — | EP | claimed |
| WO-2017103944-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2017-06-22 | — | — | WO | claimed |
| CN-106146614-A | A kind of preparation method of RGD tripeptides | 沈阳科海医药科技有限公司 | 2016-11-23 | — | — | CN | claimed |
| US-5162469-A | Copolymer of Fluoromonomer and Hydrophobic Hydrolyzable Silicone Monomer | OPTICAL RESEARCH INC. (US) | 1992-11-10 | — | — | US | claimed |
| WO-1992018548-A1 | NOVEL COMPOSITION FOR CONTACT LENSES | OPTICAL RESEARCH, INC. (US) | 1992-10-29 | — | — | WO | claimed |
| CN-116751118-B | Preparation method of chiral alpha-alkyl-alpha-benzyl tetralone compound | 苏州凯若利新材料科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-116751118-B | Preparation method of chiral alpha-alkyl-alpha-benzyl tetralone compound | 苏州凯若利新材料科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-12145139-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-11-19 | — | — | US | disclosed |
| CN-113365632-B | Aminopyrimidine compounds | 卡都瑞恩医药有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117534620-A | Preparation method of palladium-catalyzed hydrocarbon bond functionalized 2-trifluoromethyl benzimidazole compound | 六盘水师范学院 | 2024-02-09 | — | — | CN | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| US-4595765-A | Process for preparing 5,6-dihydroxyindole | CLAIROL INCORPORATED (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0182157-A2 | Ester derivatives of antibiotic L 17046 | GRUPPO LEPETIT S.p.A. (IT) | 1986-05-28 | — | — | EP | disclosed |
| EP-0092136-B1 | BENZOQUINONE DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1985-08-28 | — | — | EP | disclosed |
| US-4526719-A | Benzoquinone derivatives and production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-07-02 | — | — | US | disclosed |
| EP-0092136-A1 | Benzoquinone derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1983-10-26 | — | — | EP | disclosed |
| US-4152230-A | PHOTOOXIDATION PROCESS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | ADH1C, OTC, MLEC | ALDH1A1 1959/4885KMT2A 843/4885TDP1 4487/4885 |
| US-12145139-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, MLEC | ALDH1A1 1959/4885KMT2A 843/4885TDP1 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.